The study found that in patients with moderate and severe AD, NLRP1, NLRP3, caspase 1 and its downstream material IL-1β and IL-18 expression increased, together with prompt activation of the inflammasome closely associated with AD nerve inflammation (Saresella et al., 2016). Here, NLRP1 is linked to Alzheimer disease.